Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Henzler, T; Konstandin, S; Schmid-Bindert, G; Apfaltrer, P; Haneder, S; Wenz, F; Schad, L; Manegold, C; Schoenberg, SO; Fink, C.
Imaging of tumor viability in lung cancer: initial results using 23Na-MRI.
Rofo. 2012; 184(4):340-344
Doi: 10.1055/s-0031-1299277
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Apfaltrer Paul
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- 23Na-MRI has been proposed as a potential imaging biomarker for the assessment of tumor viability and the evaluation of therapy response but has not yet been evaluated in patients with lung cancer. We aimed to assess the feasibility of 23Na-MRI in patients with lung cancer. Three patients with stage IV adenocarcinoma of the lung were examined on a clinical 3 Tesla MRI system (Magnetom TimTrio, Siemens Healthcare, Erlangen, Germany). Feasibility of 23Na-MRI images was proven by comparison and fusion of 23Na-MRI with 1H-MR, CT and FDG-PET-CT images. 23Na signal intensities (SI) of tumor and cerebrospinal fluid (CSF) of the spinal canal were measured and the SI ratio in tumor and CSF was calculated. One chemonaive patient was examined before and after the initiation of combination therapy (Carboplatin, Gemcitabin, Cetuximab). All 23Na-MRI examinations were successfully completed and were of diagnostic quality. Fusion of 23Na-MRI images with 1H-MRI, CT and FDG-PET-CT was feasible in all patients and showed differences in solid and necrotic tumor areas. The mean tumor SI and the tumor/CSF SI ratio were 13.3 ± 1.8 × 103 and 0.83 ± 0.14, respectively. In necrotic tumors, as suggested by central non-FDG-avid areas, the mean tumor SI and the tumor/CSF ratio were 19.4 × 103 and 1.10, respectively. 23Na-MRI is feasible in patients with lung cancer and could provide valuable functional molecular information regarding tumor viability, and potentially treatment response. © Georg Thieme Verlag KG Stuttgart · New York.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenocarcinoma - diagnosis
- Adenocarcinoma - drug therapy
- Adenocarcinoma - pathology
- Aged -
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Apoptosis - drug effects
- Apoptosis - physiology
- Cell Proliferation -
- Female -
- Humans -
- Image Interpretation, Computer-Assisted - methods
- Imaging, Three-Dimensional - methods
- Lung - drug effects
- Lung - pathology
- Lung - physiopathology
- Lung Neoplasms - diagnosis
- Lung Neoplasms - drug therapy
- Lung Neoplasms - pathology
- Magnetic Resonance Imaging - methods
- Male -
- Middle Aged -
- Multimodal Imaging - methods
- Necrosis -
- Neoplasm Staging -
- Pilot Projects -
- Positron-Emission Tomography - methods
- Sodium Isotopes - analysis
- Tissue Survival - drug effects
- Tissue Survival - physiology
- Tomography, X-Ray Computed - methods
- Tumor Burden - drug effects
- Tumor Burden - physiology
- Find related publications in this database (Keywords)
- thorax
- MR functional imaging
- technical aspects
- staging